Skip to main content
. 2020 Sep 3;21(17):6417. doi: 10.3390/ijms21176417

Figure 6.

Figure 6

Atherosclerotic lesion sizes in Ldlr-/- mice treated with prodigiosin or undecylprodigiosin. Representative Oil Red O-stained atherosclerotic lesions for control (A) and P50 (B), P500 (C), U50 (D) and U500 (E) treatments. (F) Area of atherosclerotic lesions for controls and treated animals, presented as the mean ± SD (n = 7). No significant differences were observed.